The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.
More Stories
Stock market’s soft-landing rally faces CPI inflation test. Here’s what investors should do.
Middle East tensions, the port strike and the Fed’s interest-rate outlook puts inflation front and center again for the U.S....
Third-quarter earnings are upon us. So are worries of slower growth.
This summer, restaurants and many retailers who weren’t Walmart warned of a struggling consumer.
Trump and Harris say they want to cut taxes. Here’s why you should prepare for a tax hike.
Whoever wins November’s presidential election will be faced with an immediate need to negotiate with Congress over what income-tax rates...
Finding the best 529 college-savings plan is easier than you think. Here’s what matters most.
Simplify your decision-making so you can focus on saving.
My friend inherited a $160,000 house. Will this put her Social Security disability income at risk? What can she do?
‘She really needs the money to make improvements to her house.’
‘I don’t want her to lose money’: A real-estate agent said she’d take out an ad to help me find a renter. Am I now morally obligated to use her?
“Other agents know our apartment is available for rent and now want to show it.”